ORCA-010, a Novel Potency-Enhanced Oncolytic Adenovirus, Exerts Strong Antitumor Activity in Preclinical Models

W.L. Dong, J.W.H. van Ginkel, K.Y. Au, R Alemany, J.J.M. Meulenberg, V.W. van Beusechem

Research output: Contribution to journal › Article › Academic › peer-review

22 Citations (Scopus)

Access to Document

@article{0dee1603d95341759a22f286f5efe4ce,

title = "ORCA-010, a Novel Potency-Enhanced Oncolytic Adenovirus, Exerts Strong Antitumor Activity in Preclinical Models",

author = "W.L. Dong and {van Ginkel}, J.W.H. and K.Y. Au and R Alemany and J.J.M. Meulenberg and {van Beusechem}, V.W.",

year = "2014",

doi = "https://doi.org/10.1089/hum.2013.229",

language = "Undefined/Unknown",

volume = "25",

pages = "897--904",

journal = "Human gene therapy",

issn = "1043-0342",

publisher = "Mary Ann Liebert Inc.",

number = "10",

}

TY - JOUR

T1 - ORCA-010, a Novel Potency-Enhanced Oncolytic Adenovirus, Exerts Strong Antitumor Activity in Preclinical Models

AU - Dong, W.L.

AU - van Ginkel, J.W.H.

AU - Au, K.Y.

AU - Alemany, R

AU - Meulenberg, J.J.M.

AU - van Beusechem, V.W.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.1089/hum.2013.229

DO - https://doi.org/10.1089/hum.2013.229

M3 - Article

C2 - 25093639

SN - 1043-0342

VL - 25

SP - 897

EP - 904

JO - Human gene therapy

JF - Human gene therapy

IS - 10

ER -